telcagepant potassium

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

MigraineMigraine Disorders

Phase 1

Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026)

CompletedNCT00701389

Merck Sharp & Dohme LLCMigraine Disorders

Start: 2007-11-20End: 2008-04-10Updated: 2018-10-17

Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED)

CompletedNCT01209741

Merck Sharp & Dohme LLCMigraine

Start: 2007-10-31End: 2007-11-30Updated: 2015-08-18